Study guide

12.2 Ex Parte Reexamination & Supplemental Examination

USPTO Registration Examination Patent Bar

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview, Registration & MPEP Structure

1.1 Patent Bar Exam Format & Administration 1.2 Practitioner Qualifications & Eligibility 1.3 MPEP Structure & Effective Search Strategies

2 Chapter 2: Subject Matter Eligibility & Utility (35 U.S.C. § 101)

2.1 Patent-Eligible Subject Matter & Statutory Categories 2.2 Judicial Exceptions & the Alice/Mayo Framework 2.3 Utility Requirements & USPTO Utility Guidelines

3 Chapter 3: Novelty & Prior Art Under the AIA (35 U.S.C. § 102)

3.1 First-Inventor-to-File (FITF) & Effective Filing Dates 3.2 The One-Year Inventor Grace Period & Exceptions 3.3 Prior Art Types & Public Availability Standards

4 Chapter 4: Nonobviousness Analysis (35 U.S.C. § 103)

4.1 The Graham Factors & KSR Obviousness Framework 4.2 Combining Prior Art References & Motivation to Combine 4.3 Overcoming § 103 Rejections & Rule 132 Affidavits

5 Chapter 5: Specification & Disclosure Requirements (35 U.S.C. § 112(a))

5.1 Written Description Requirement 5.2 Enablement Requirement & Wands Factors 5.3 Best Mode Requirement & Current Post-AIA Status

6 Chapter 6: Claim Requirements & Definiteness (35 U.S.C. § 112(b)-(f))

6.1 Definiteness & Claim Precision 6.2 Independent & Dependent Claim Construction 6.3 Special Claim Formats: Means-Plus-Function & Markush Claims

7 Chapter 7: Application Types & Filing Procedures (MPEP Chapter 600)

7.1 Provisional Patent Applications 7.2 Nonprovisional Application Parts & Formalities 7.3 Inventor Oaths, Declarations & Assignments

8 Chapter 8: Duty of Disclosure & Information Disclosure Statements

8.1 Duty of Candor & Good Faith 8.2 Information Disclosure Statements (IDS) Requirements 8.3 Correcting Non-Disclosure & Duty Compliance

9 Chapter 9: Patent Prosecution & Office Action Responses (MPEP Chapter 700)

9.1 Initial Examination & Non-Final Office Actions 9.2 Statutory Deadlines & Extension of Time 9.3 Final Office Actions & Post-Final Practice

10 Chapter 10: Continuing Applications & Copendency

10.1 Continuation Applications 10.2 Divisional Applications 10.3 Continuation-in-Part (CIP) Applications & Priority Allocation

11 Chapter 11: Appeals & Interferences/Derivation (MPEP Chapter 1200 & 2300)

11.1 Ex Parte Appeals to the PTAB 11.2 PTAB Appeal Decisions & Judicial Review 11.3 Derivation Proceedings Under the AIA

12 Chapter 12: Post-Grant Proceedings & Corrections (MPEP Chapters 1400 & 2200)

12.1 Reissue Applications & Certificates of Correction 12.2 Ex Parte Reexamination & Supplemental Examination 12.3 Inter Partes Review (IPR) & Post-Grant Review (PGR)

13 Chapter 13: Patent Term, Maintenance Fees & Ownership

13.1 Patent Term Calculation & Patent Term Adjustment (PTA) 13.2 Maintenance Fees & Expiration 13.3 Inventorship, Ownership & Assignment Recordation 13.4 Patent Term Extension Under 35 U.S.C. § 156

14 Chapter 14: International Patent Practice & PCT (MPEP Chapter 1800)

14.1 The Patent Cooperation Treaty (PCT) Overview 14.2 PCT International Phase & Chapter I / Chapter II 14.3 National Phase Entry Under 35 U.S.C. § 371

15 Chapter 15: Special Patent Categories & Professional Conduct

15.1 Design Patents & Plant Patents 15.2 USPTO Rules of Professional Conduct 15.3 Patent Bar Exam Strategy & Open-Book Navigation Tips

16 Chapter 16: Security, Access, Representation & Filing Mechanics

16.1 Secrecy, Application Access & Foreign Filing Licenses 16.2 Representation, Power of Attorney & Correspondence 16.3 Filing Receipt, Certificates of Transmission & Signatures

17 Chapter 17: Restriction, Publication, Allowance & Office Authority

17.1 Restriction, Election, Rejoinder & Double Patenting 17.2 Publication, Preissuance Submissions & Protests 17.3 Allowance, Issue Fee & Withdrawal from Issue 17.4 Examiner Interviews, Petitions & Office Authority

18 Chapter 18: Biotechnology Disclosure & Patent Prosecution Highway

18.1 Biological Deposits & Sequence Listings 18.2 Global/IP5 Patent Prosecution Highway

19 Chapter 19: AIA Trial Practice Under the Consolidated Guide

19.1 AIA Trial Petitions, Preliminary Response & Institution 19.2 AIA Trial Discovery, Motions, Hearing & Final Decision

12.2 Ex Parte Reexamination & Supplemental Examination

Key Takeaways Explain This Topic AI

Ex Parte Reexamination under 35 U.S.C. § 302 can be requested by anyone (patent owner or third party) based ONLY on prior art patents and printed publications.

The statutory threshold for ordering ex parte reexamination is establishing a Substantial New Question of Patentability (SNQ).

Third-party requester participation in ex parte reexamination ends after the initial petition and reply phase; the proceeding thereafter is conducted strictly ex parte with special dispatch.

Under 35 U.S.C. § 305, claims cannot be broadened during ex parte reexamination under any circumstances.

Only the patent owner may request supplemental examination; § 257(c) protection is subject to pre-request pleading/drug-notice exceptions and, for an owner-filed infringement action, completion before that action.

Last updated: August 2026

Ex Parte Reexamination & Supplemental Examination

Post-grant administrative proceedings allow the USPTO to re-evaluate the patentability of issued claims. Two essential proceedings governed by MPEP Chapters 2200 and 2800 are Ex Parte Reexamination (enacted in 1980) and Supplemental Examination (created by the Leahy-Smith America Invents Act in 2012). While both proceedings can lead to reexamination of issued claims, they serve distinct purposes, have different standing requirements, and accept drastically different types of evidence.

Ex Parte Reexamination (35 U.S.C. §§ 301–307 & MPEP Chapter 2200)

Ex Parte Reexamination permits any person—including the patent owner, a competitor, or an anonymous third party—to request that the USPTO reexamine an unexpired patent based on prior art.

Prior Art Limitations (35 U.S.C. § 301 & § 302)

Reexamination requests under 35 U.S.C. § 302 are strictly limited to prior art consisting of patents and printed publications . Ex parte reexamination cannot be based on:

  • Prior public use or commercial sale evidence;
  • Ineligibility under 35 U.S.C. § 101;
  • Indefiniteness, lack of enablement, or inadequate written description under 35 U.S.C. § 112;

Inventorship disputes or inequitable conduct allegations.

Substantial New Question of Patentability (SNQ)

Within three months of receiving an ex parte reexamination request, the USPTO Director must determine whether the cited prior art raises a Substantial New Question of Patentability (SNQ) (35 U.S.C. § 304 & MPEP 2240).

An SNQ exists if a reasonable examiner would consider the prior art teaching important in deciding whether the claim is patentable.

To constitute a new question, the prior art patents or printed publications must not have been previously considered during original prosecution or prior reexaminations, OR must present a new technical teaching that was not previously applied by the Office. +-----------------------------------------------------------------------------------+

  • | EX PARTE REEXAMINATION TIMELINE & STEPS |
  • +-----------------------------------------------------------------------------------+
  • | 1. Request filed under § 302 (Patents & Printed Publications only). |
  • | 2. USPTO issues SNQ Determination within 3 MONTHS. |
  • | -> If No SNQ: Request denied; portion of fee refunded; proceeding ends. |
  • | -> If SNQ Found: Order for Ex Parte Reexamination issued. |
  • | 3. Patent Owner Statement (optional, within 2 months of Order). |
  • | 4. Requester Reply (optional, within 2 months of PO Statement). |
  • | 5. Proceeding continues EX PARTE with special dispatch between USPTO & Patent Owner. |
  • +-----------------------------------------------------------------------------------+
  • Conduct of Examination & Special Dispatch (MPEP 2261)

Once an ex parte reexamination is ordered, third-party requester participation terminates completely (unless a Patent Owner statement was filed, allowing a one-time third-party reply). The proceeding is conducted ex parte between the USPTO examiner and the Patent Owner with special dispatch (MPEP 2261).

Claim Amendments (35 U.S.C. § 305)

During reexamination, the Patent Owner may propose amendments to claims or submit new claims to distinguish over the prior art. However, 35 U.S.C. § 305 strictly prohibits any amendment that enlarges or broadens the scope of the claims . Reexamination claims may only be narrowed or maintained in scope.

Supplemental Examination (35 U.S.C. § 257 & MPEP Chapter 2800)

Supplemental Examination was created under the America Invents Act (AIA) to give patent owners a mechanism to request that the USPTO evaluate, consider, or correct information believed to be relevant to the patent.

Key Differences from Ex Parte Reexamination

Standing: Only the Patent Owner may file a request for Supplemental Examination (35 U.S.C. § 257(a)). Third parties cannot request it.

Scope of Information: Unlike ex parte reexamination, information submitted in supplemental examination is NOT restricted to patents and printed publications . A patent owner can submit any information, including sales records, public use evidence, transcripts, § 112 enablement concerns, or expert declarations.

Statutory Procedure & Standard

Within 3 months of receiving a request for supplemental examination, the USPTO must issue a Supplemental Examination Certificate indicating whether the submitted information raises an SNQ.

If an SNQ is found , the USPTO Director will automatically order an ex parte reexamination of the patent (which will then proceed under the rules of ex parte reexamination).

If no SNQ is found , the supplemental examination concludes, and a certificate issuing the determination is published.

Inequitable Conduct Safe Harbor (35 U.S.C. § 257(c))

A primary motivation for filing Supplemental Examination is to insulate a patent against future charges of inequitable conduct in district court litigation. Under 35 U.S.C. § 257(c):

Information considered, reconsidered, or corrected through supplemental examination generally cannot support an inequitable-conduct holding under § 257(c).

Pre-request allegations: The protection does not displace an inequitable-conduct allegation pled with particularity before the supplemental-examination request, or the statute’s specified pre-request drug-approval notice circumstances.

Patent-owner enforcement: If the patent owner brings an infringement action, the supplemental examination and any ordered reexamination must be completed before that action is filed for the protection to operate there.

Comparative Analysis: Reexamination vs. Supplemental Examination

  • Feature Ex Parte Reexamination Supplemental Examination
  • Statutory Basis 35 U.S.C. § 302 35 U.S.C. § 257
  • Who May Request? Anyone (PO, third party, anonymous) Patent Owner ONLY
  • Permissible Prior Art / Info Patents & Printed Publications ONLY Any information (sales, § 112, use)
  • Threshold Standard Substantial New Question (SNQ) Substantial New Question (SNQ)
  • USPTO Decision Window 3 Months 3 Months
  • Broadening Claims Allowed? NO (Strictly Prohibited under § 305) NO
  • Inequitable Conduct Safe Harbor? No express safe harbor YES (under 35 U.S.C. § 257(c))

Loading diagram... Ex Parte Reexamination & Supplemental Examination Pathways